J&J seeks to stop Samsung Bioepis from licensing Stelara biosimilar

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Make caregiving a defining issue of the 2024 election

Kamala Harris, the current vice president and now Democratic candidate for president, made a bold statement in her inaugural campaign speech by shining a spotlight

August 1, 2024

Could This Neuroleptic Ward Off RA?

Patients taking haloperidol were significantly less likely to develop new-onset rheumatoid arthritis (RA), relative to those receiving other antipsychotic medications, researchers found. Data pooled from

September 14, 2023

Augmedics Raises $82.5M for Augmented Reality Spine Surgery Platform

What You Should Know: Augmedics, a Chicago-based provider of augmented reality (AR) surgical navigation raises $82.5M in Series D funding led by CPMG and adds

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.